These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6817438)

  • 21. Freeze-drying of protein pharmaceuticals--the application of thermal analysis.
    Kett V; McMahon D; Ward K
    Cryo Letters; 2004; 25(6):389-404. PubMed ID: 15660166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coalescence stability of emulsions containing globular milk proteins.
    Tcholakova S; Denkov ND; Ivanov IB; Campbell B
    Adv Colloid Interface Sci; 2006 Nov; 123-126():259-93. PubMed ID: 16854363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance.
    Edwards AD; Slater NK
    Vaccine; 2008 Oct; 26(45):5675-8. PubMed ID: 18761389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interferon. An overview of the state of basic research with special regard to interferon-gamma].
    Günther G; Otto B
    Arzneimittelforschung; 1993 Feb; 43(2):182-8. PubMed ID: 7681288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alpha interferons--new therapeutic modalities].
    Bajcetić M; Zigon N; Samardzić R; Beleslin DB
    Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibodies against alpha-2 and gamma-interferons affect the course of juvenile respiratory papillomatosis in children treated with alpha-2 interferon preparations].
    Kol'tsov VD; Onufrieva EK; Nurmukhamedov RKh; Malinovskaya VV; Yershov FI
    Vestn Otorinolaringol; 1997; (4):13-5. PubMed ID: 9334008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Classical Pathway of Complement Activation by Interferons.
    Lebedeva TV; Kozlov LV
    Russ J Immunol; 1997 Jul; 2(2):129-134. PubMed ID: 12687067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
    Kunzmann V; Kretzschmar E; Herrmann T; Wilhelm M
    Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon as a treatment tool of cancer].
    Sakurai Y
    Gan No Rinsho; 1983 May; 29(6):579-83. PubMed ID: 6876427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of murine and human interferons. A review of the literature of the 1970s.
    Berg K
    Acta Pathol Microbiol Immunol Scand Suppl; 1982; 279():1-136. PubMed ID: 6182743
    [No Abstract]   [Full Text] [Related]  

  • 33. [The first answer to viral infections: type I interferon].
    Pichlmair A; Pollak M; Bergthaler A
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Betaseron.
    Lin L
    Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of physicochemical factors on the thermal inactivation of murine interferon.
    Jariwalla R; Grossberg SE; Sedmak JJ
    Arch Virol; 1975; 49(2-3):261-72. PubMed ID: 2143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferons alpha, beta and gamma induce different patterns of gene expression in cultured human epidermal keratinocytes.
    Arany I; Arany M; Brysk H; Tyring SK; Brysk MM
    In Vivo; 1997; 11(2):157-61. PubMed ID: 9179609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.